HomeOpen Access NewsContributor Profile

Contributor Profile

Intelligent document processing: Transforming public sector efficiency

Given the challenges public sector organisations face with excessive paperwork, Intelligent Document Processing (IDP) offers a solution to enhance efficiency by automating document capture, extraction, classification, and decision-making.

Solar Farms: Changing how we power the UK

Grant Folley, Head of Origination & Planning at EDF Renewables UK, focuses on solar, which he argues is changing how we power the UK.

Placecube asks: What does your digital place look like?

Jason Fahy, Chief Executive Officer at Placecube, explains how the public sector is using its open-source, low-code, Digital Experience Platform, Digital Place, to accelerate its digital transformation.

Digital infrastructure to connect all communities

Ian Newbury, Business Development Director, Mobile Network Operators & Digital Infrastructure at BT Wholesale, examines how to open the gateway to digital infrastructure that connects all communities.

Should the wider population be paying attention to their blood sugar levels?

Diabetes represents a huge burden on health systems and sufferers, but accurately monitoring blood sugar levels could help people to take control of their health before more serious issues come to light.

Plug making green hydrogen a reality in Europe and beyond

In late September, Germany and England joined forces to propel the industry forward with green hydrogen. Combined with series of other initiatives, Plug sees this declaration as an encouraging signal for the development of the green hydrogen sector.

Inhealthcare: Creating services to help the NHS tackle the growing backlog of elective care

Bryn Sage, CEO of remote patient monitoring provider Inhealthcare, explains how the company’s digital health technology is helping to ease pressures across the NHS, reduce hospital admissions, and improve patients’ health outcomes.

Multiple sclerosis – the disease of a thousand faces

Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?

Unraveling the potential of antisense therapies to target neuropilin 1 in the fight against cancer

Secarna Pharmaceuticals, the next-generation antisense drug discovery and development company, is developing novel approaches to successfully target Neuropilin 1 (NRP1), a promising target for the treatment of cancer.

Smart integrated lighting and control solutions to support your decarbonisation initiatives

Urbis Schréder walks us through their smart LED lighting and control solutions for city centres, roads, bridges, tunnels, buildings, and workspaces.

More on digital transformation in the NHS

Ben Riley, Director of Aventius, examines more on digital transformation in the NHS.

Antisense therapies: A new approach to tackling challenging targets in areas of high unmet medical need

Alexander Gebauer, the Chief Executive Officer at Secarna Pharmaceuticals GmbH & Co. KG looks at a new approach to solve unmet medical needs with...

Energy Unlocked: Why AI cannot solve net zero local energy transitions

Molly Webb, Founder and CEO of Energy Unlocked, explores why the promise of ‘smart’ technologies has yet to be realised in urban areas.

Utilising frameworks to leverage the best hybrid communication suppliers

Nicki Newburn from, CFH Docmail Ltd, highlights utilising frameworks to leverage the best hybrid communication suppliers.

Engineering skills for the climate emergency

It’s not too late to respond to the challenges of the climate emergency – but only if we fast-track vital engineering skills into our economy before 2030 – The Royal Academy of Engineering explains.

Hydrogen refuelling station at new dimensions

Dr. Stefan Rehm, Managing Director of Hypion GmbH, presents the logic of integrated hydrogen hubs as concept to decarbonise heavy duty road transportation.

Secarna aims to expand the therapeutic toolbox against cancer

Current oncology treatments have significantly improved cancer survival rates, but more effective and safer therapeutics are needed.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders